GlaxoSmithKline
NEWS
Sanofi has announced major restructuring, which will involve about 400 job cuts in the U.S.
This Latest move is a wide-ranging effort to boost competitiveness.
Speculation around a possible bid has mounted in recent months.
GlaxoSmithKline CEO Emma Walmsley is eying a big acquisition to spur revenue growth but is making sure that her company will not overpay.
GlaxoSmithKline CEO Emma Walmsley is not done reshaping her leadership team as she continues to overhaul the company’s pharmaceutical division.
Under terms of the deal, Boehringer has the option to acquire Autifony’s Kv3.1/3.2 positive modulator platform, which includes the company’s lead compound AUT00206.
GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.
It’s no secret that the life sciences are increasingly international.
Glaxo has a bold future planned for its R&D facility in Maryland.
JOBS
IN THE PRESS